Nanobiotix (NASDAQ:NBTX – Get Rating) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, September 28th. Parties interested in listening to the company's conference call can do so using this link.
Nanobiotix Price Performance
Shares of NBTX opened at $3.95 on Monday. Nanobiotix has a 12-month low of $2.32 and a 12-month high of $13.37. The firm has a 50-day moving average price of $3.98 and a 200 day moving average price of $4.94.
Get Nanobiotix alerts:About Nanobiotix
(Get Rating)
Nanobiotix SA, a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.See Also
- Get a free copy of the StockNews.com research report on Nanobiotix (NBTX)
- Can Caterpillar Claw Higher in a Falling Market?
- Is Dave & Buster's Immune to High Inflation and Lower Spending?
- Should These 3 Top-Performing Mid-Caps Be On Your Watchlist?
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
Receive News & Ratings for Nanobiotix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanobiotix and related companies with MarketBeat.com's FREE daily email newsletter.